The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.
Arthritis Res Ther
; 18: 195, 2016 09 01.
Article
in En
| MEDLINE
| ID: mdl-27586891
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Buspirone
/
Esophageal Motility Disorders
/
Serotonin 5-HT1 Receptor Agonists
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Arthritis Res Ther
Journal subject:
REUMATOLOGIA
Year:
2016
Document type:
Article
Affiliation country:
Grecia
Country of publication:
Reino Unido